Small News Arriello

WDSC Americas, 20-21 October in Boston!

Missing image

We’re also at WDSC Americas, 20-21 October in Boston!
Arriello is a Platinum sponsor at the World Drug Safety Congress Americas in Boston, and we’re carrying over most of our line-up from the WDSC Amsterdam event during the two days.

In the Next Generation Tech & Data track, Arriello Pharmacovigilance Advisory Board member Dr. John Price will be presenting key findings from our latest transatlantic PV automation adoption survey report, which gets right to the heart of what PV professionals really want, their priorities, the effects of Covid on adoption and more.

And following on from this on day two, John will be hosting round table session #1 in the afternoon where you’ll get the chance to discuss the findings with him in more detail and add to the conversation.

We are also showcasing IntelliCASE, our mobile case intake system at STAND #23, where you can try out a demo version for yourself and see how easy it is use, including speech to text input. Our team will be on hand to walk you through the product, answer questions and discuss the many scenarios where it can integrate into your existing systems and processes.

The team is always available for meetings through the event’s Swapcard networking platform, so just reach out to our guys to get talking about our PV and Auditing services and a personal IntelliCASE demo. 

Latest News

We are pleased to announce our sponsorship of an event for CMOs in Co. Cork, Ireland, held by PDA Ireland Chapter.
Sponsoring & Exhibiting at PDA Ireland Event for CMOs.
Monika Čičová, Arriello’s Quality & Compliance Specialist – Auditing and Quality Assurance, will be presenting at the Conforum: “Farmakovigilance aktuálně a přehledně” 2024 conference.
Third Party Audit Management Presentation at Conforum 2024.
Our experts will describe how integrating all functions into a comprehensive and holistic regulatory strategy is the key for optimizing regulatory frameworks.
Open Registration: New Webinar on Pharma Regulatory Strategy.